Autolus Therapeutics (AUTL) U.S. CCO reports option and RSU holdings

Rhea-AI Filing Summary

Autolus Therapeutics plc executive Cintia Piccina, U.S. CCO & Country General Manager, has filed a Form 3 reporting her existing equity awards. She holds share options over 500,000 American Depositary Shares at an exercise price of $1.49 expiring on October 8, 2035, and options over 148,000 ADS at $1.62 expiring on March 4, 2036. She also holds restricted share units covering 80,000 ADS that vest in four equal annual installments starting on September 1, 2026, and 33,000 RSUs vesting in four equal annual installments starting on March 4, 2027, with each RSU representing one ADS.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Piccina Cintia

(Last) (First) (Middle)

C/O AUTOLUS THERAPEUTICS PLC

THE MEDIAWORKS, 191 WOOD LN, WHITE CITY

(Street)

LONDON W12 7FP

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Autolus Therapeutics plc [ AUTL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	U.S. CCO & Country Gen Manager

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option (right to buy)	(1)	10/08/2035	American Depositary Shares	500,000	$1.49	D
Share Option (right to buy)	(2)	03/04/2036	American Depositary Shares	148,000	$1.62	D
Restricted Share Units	(3)	(3)	American Depositary Shares	80,000	(4)	D
Restricted Share Units	(5)	(5)	American Depositary Shares	33,000	(4)	D

Explanation of Responses:

1. This option vests 25% on October 8, 2026 and the remainder vests in 36 equal monthly installments thereafter.

2. This option vests 25% on March 4, 2027 and the remainder vests in 36 equal monthly installments thereafter.

3. The restricted share units ("RSUs") vest in four equal annual installments commencing on September 1, 2026.

4. Each RSU represents a contingent right to receive one Issuer American Depositary Share.

5. The RSUs vest in four equal annual installments commencing on March 4, 2027.

	/s/ Cintia Piccina	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Form 3 filing show for Autolus Therapeutics (AUTL) executive Cintia Piccina?

The Form 3 records Cintia Piccina’s existing equity awards in Autolus. It lists her holdings of share options and restricted share units tied to American Depositary Shares, including exercise prices, expiration dates, and multi-year vesting schedules, but no new market purchases or sales.

How many Autolus (AUTL) options does Cintia Piccina report holding?

She reports two option positions over American Depositary Shares. One covers 500,000 ADS at an exercise price of $1.49 expiring October 8, 2035. The second covers 148,000 ADS at an exercise price of $1.62 expiring March 4, 2036, both held directly.

What restricted share unit (RSU) awards are disclosed for Autolus (AUTL) in this Form 3?

The filing shows two RSU awards. One covers 80,000 RSUs vesting in four equal annual installments starting September 1, 2026. Another covers 33,000 RSUs vesting in four equal annual installments starting March 4, 2027. Each RSU converts into one American Depositary Share.

Does the Autolus (AUTL) Form 3 for Cintia Piccina include any stock purchases or sales?

No, it does not report any stock purchases or sales. All entries are classified as holdings of options and restricted share units, with transaction summaries showing zero buys, zero sells, and only holding entries, making this an administrative ownership disclosure.

How do the Autolus (AUTL) RSU awards for Cintia Piccina vest over time?

The 80,000 RSUs vest in four equal annual installments beginning September 1, 2026. The 33,000 RSUs vest in four equal annual installments beginning March 4, 2027. This structure spreads potential share delivery gradually across several years, contingent on continuing service and vesting.